These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26722022)

  • 41. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytoprotective effect of amifostine in radiation-induced acute mucositis - a retrospective analysis.
    Kouvaris J; Kouloulias V; Kokakis J; Matsopoulos G; Balafouta M; Miliadou A; Vlahos L
    Onkologie; 2002 Aug; 25(4):364-9. PubMed ID: 12232489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In regard to Antonadou et al. Randomized trial investigating the effects of daily amifostine in addition to radiation therapy in 146 patients with advanced lung cancers.
    Dubray B; Dhermain F
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1395-6; author reply 1396. PubMed ID: 12128148
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy.
    Chen C; Uyterlinde W; Sonke JJ; de Bois J; van den Heuvel M; Belderbos J
    Radiother Oncol; 2013 Aug; 108(2):337-41. PubMed ID: 24074814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A meta-analysis of Shenqi Fuzheng combined with radiation in the treatment of nonsmall cell lung cancer.
    Jiang H; Zhang H; Hu X; Ma J
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C101-3. PubMed ID: 26323903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new administration schedule for amifostine as a radioprotector in cancer therapy.
    Wagner W; Radmard A; Schönekaes KG
    Anticancer Res; 1999; 19(3B):2281-3. PubMed ID: 10472344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial.
    Athanassiou H; Antonadou D; Coliarakis N; Kouveli A; Synodinou M; Paraskevaidis M; Sarris G; Georgakopoulos GR; Panousaki K; Karageorgis P; Throuvalas N;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1154-60. PubMed ID: 12829154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
    Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
    Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP; Mehta MP
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential role of amifostine in the treatment of non small cell lung cancer.
    Castiglione F; Porcile G; Gridelli C
    Lung Cancer; 2000 Jul; 29(1):57-66. PubMed ID: 10880848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
    Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer.
    Wiersma TG; Dahele M; Verbakel WF; van de Ven PM; de Haan PF; Smit EF; van Reij EJ; Slotman BJ; Senan S
    Lung Cancer; 2013 Apr; 80(1):62-7. PubMed ID: 23357464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
    Vardy J; Wong E; Izard M; Clifford A; Clarke SJ
    Anticancer Drugs; 2002 Mar; 13(3):327-30. PubMed ID: 11984077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer.
    Or M; Liu B; Lam J; Vinod S; Xuan W; Yeghiaian-Alvandi R; Hau E
    Sci Rep; 2021 Mar; 11(1):5939. PubMed ID: 33723301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer: a meta-analysis.
    Qian H; Wang H; Guan X; Yi Z; Ma F
    Anticancer Drugs; 2016 Jun; 27(5):433-8. PubMed ID: 26872311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
    Duval M; Daniel SJ
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):309-15. PubMed ID: 23092832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.